Left ventricular hypertrophy in hypertension: etiology, treatment, and controversies.
Phillips
R A
RA
Hypertension Section, Mount Sinai School of Medicine, New York, New York 10029, USA.
Diamond
J A
JA
Gharavi
A
A
D000450:Aldosterone / Q000502:physiology; D000804:Angiotensin II / Q000502:physiology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000808:Angiotensinogen / Q000502:physiology; D000818:Animals; D006439:Hemodynamics; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000503:physiopathology; D017379:Hypertrophy, Left Ventricular / Q000150:complications / Q000209:etiology / Q000503:physiopathology* / Q000628:therapy; D012307:Risk Factors
D000806:Angiotensin-Converting Enzyme Inhibitors; D000808:Angiotensinogen; D000804:Angiotensin II; D000450:Aldosterone